<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(5)</volume><submitter>Terrier LM</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Anaplastic gangliogliomas (GGGs) are rare tumors whose natural history is poorly documented. We aimed to define their clinical and imaging features and to identify prognostic factors.&lt;h4>Methods&lt;/h4>Consecutive cases of anaplastic GGGs in adults prospectively entered into the French Brain Tumor Database between March 2004 and April 2014 were screened. After diagnosis was confirmed by pathological review, clinical, imaging, therapeutic, and outcome data were collected retrospectively.&lt;h4>Results&lt;/h4>Forty-three patients with anaplastic GGG (median age, 49.4 y) from 18 centers were included. Presenting symptoms were neurological deficit (37.2%), epileptic seizure (37.2%), or increased intracranial pressure (25.6%). Typical imaging findings were unifocal location (94.7%), c</pubmed_abstract><journal>Neuro-oncology</journal><pagination>678-688</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5464461</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database.</pubmed_title><pmcid>PMC5464461</pmcid><pubmed_authors>Le Reste PJ</pubmed_authors><pubmed_authors>Aubriot-Lorton MH</pubmed_authors><pubmed_authors>Pallud J</pubmed_authors><pubmed_authors>Caille A</pubmed_authors><pubmed_authors>Milin S</pubmed_authors><pubmed_authors>Loiseau H</pubmed_authors><pubmed_authors>Wager M</pubmed_authors><pubmed_authors>Terrier LM</pubmed_authors><pubmed_authors>Amelot A</pubmed_authors><pubmed_authors>Bergemer-Fouquet AM</pubmed_authors><pubmed_authors>Filipiak I</pubmed_authors><pubmed_authors>Voirin J</pubmed_authors><pubmed_authors>Lubrano V</pubmed_authors><pubmed_authors>Almairac F</pubmed_authors><pubmed_authors>Janot K</pubmed_authors><pubmed_authors>Zanello M</pubmed_authors><pubmed_authors>Francois P</pubmed_authors><pubmed_authors>Velut S</pubmed_authors><pubmed_authors>Mandonnet E</pubmed_authors><pubmed_authors>Uro-Coste E</pubmed_authors><pubmed_authors>Vital A</pubmed_authors><pubmed_authors>Dam Hieu P</pubmed_authors><pubmed_authors>Emery E</pubmed_authors><pubmed_authors>Menei P</pubmed_authors><pubmed_authors>Guyotat J</pubmed_authors><pubmed_authors>Roche PH</pubmed_authors><pubmed_authors>Rigau V</pubmed_authors><pubmed_authors>Metellus P</pubmed_authors><pubmed_authors>Figarella-Branger D</pubmed_authors><pubmed_authors>Rousseau A</pubmed_authors><pubmed_authors>Debono B</pubmed_authors><pubmed_authors>Zemmoura I</pubmed_authors><pubmed_authors>Liguoro D</pubmed_authors><pubmed_authors>Club de Neuro-Oncologie of the Société Française de Neurochirurgie</pubmed_authors><pubmed_authors>Muckenstrum B</pubmed_authors><pubmed_authors>Godfraind C</pubmed_authors><pubmed_authors>Irthum B</pubmed_authors><pubmed_authors>Delisle MB</pubmed_authors><pubmed_authors>Czorny A</pubmed_authors><pubmed_authors>Varlet P</pubmed_authors><pubmed_authors>Bord E</pubmed_authors><pubmed_authors>Zouaoui S</pubmed_authors><pubmed_authors>Cornu P</pubmed_authors><pubmed_authors>Gauchotte G</pubmed_authors><pubmed_authors>Farah W</pubmed_authors><pubmed_authors>Lot G</pubmed_authors><pubmed_authors>Bauchet L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database.</name><description>&lt;h4>Background&lt;/h4>Anaplastic gangliogliomas (GGGs) are rare tumors whose natural history is poorly documented. We aimed to define their clinical and imaging features and to identify prognostic factors.&lt;h4>Methods&lt;/h4>Consecutive cases of anaplastic GGGs in adults prospectively entered into the French Brain Tumor Database between March 2004 and April 2014 were screened. After diagnosis was confirmed by pathological review, clinical, imaging, therapeutic, and outcome data were collected retrospectively.&lt;h4>Results&lt;/h4>Forty-three patients with anaplastic GGG (median age, 49.4 y) from 18 centers were included. Presenting symptoms were neurological deficit (37.2%), epileptic seizure (37.2%), or increased intracranial pressure (25.6%). Typical imaging findings were unifocal location (94.7%), c</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 May</publication><modification>2025-05-29T20:48:27.04Z</modification><creation>2025-05-29T20:48:27.04Z</creation></dates><accession>S-EPMC5464461</accession><cross_references><pubmed>28453747</pubmed><doi>10.1093/neuonc/now186</doi></cross_references></HashMap>